Related Experiment Video
Updated: Jul 22, 2026

Measuring Attentional Biases for Threat in Children and Adults
Published on: October 19, 2014
Attention-Deficit/Hyperactivity Disorder as a Risk Factor for COVID-19 Infection
Herman Avner Cohen1,2, Maya Gerstein1,2, Noga Yaniv3
1Pediatric Ambulatory Community Clinic, Petach Tikva, Israel.
Objective:
To postulate that ADHD is a potential risk factor for COVID-19 infection; to evaluate the COVID-19 risk factor on drug-treated ADHD subjects.
Methods:
A retrospective chart review was performed on ADHD subjects aged 6 to 18 years in Israel, who had undergone at least one COVID-19 test during the study period.
Results:
Of the 64,409 subjects included in the study, 6,207 (9.64%) had at least one positive COVID-19 test result, 13,300 (20.65%) were diagnosed with ADHD, and of whom 1,751 (13%) had purchased at least two ADHD medications 3 months prior to COVID-19 testing and were defined as being medically treated. Medically-treated ADHD subjects had a significantly lower likelihood to be infected with COVID-19 than untreated subjects.
Conclusion:
Untreated ADHD patients seem to constitute a risk group for COVID-19 infection. Drug treatment ameliorates risk of spreading COVID-19 infection within the pediatric population and secondary spread in the general population.
More Related Videos
Related Concept Videos
Generalized Anxiety Disorder
Panic Disorder
Social Anxiety Disorder
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Amebiasis

